Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
Most Know Kids Can Die From Flu, Yet Many Still Haven’t Had Children Vaccinated Featured News November 8, 2018 …
Antibiotic Resistance Could Take Us Back To the ‘Dark Ages’ Antimicrobial Resistance November 6, 2018 …
Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker Featured News October 29, 2018 …
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox Medical Countermeasures October 4, 2018 …
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding Contracts + Grants September 20, 2018 …
CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine Medical Countermeasures August 12, 2018 …
Landmark Ebola Study Provides Deep Scan of Therapeutic Antibody Combinations Medical Countermeasures August 9, 2018 …
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994 Antimicrobial Resistance July 16, 2018 …
Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine Medical Countermeasures July 12, 2018 …
MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments Medical Countermeasures May 18, 2018 …
